Boucher Jason 4

4 · American Renal Associates Holdings, Inc. · Filed Mar 28, 2019

Form 4

Period: 2019-03-26

VP & Chief Accounting Officer

Transactions

Other
Stock Option (Right to Buy)
2019-03-26−7,939→ 0 total
Exercise: $6.47Exp: 2023-03-22→ Common Stock (7,939 underlying)
Other
Stock Option (Right to Buy Common Stock)
2019-03-26−4,800→ 0 total
Exercise: $17.39Exp: 2027-03-10→ Common Stock (4,800 underlying)
Other
Stock Option (Right to Buy Common Stock)
2019-03-26−15,649→ 0 total
Exercise: $15.76Exp: 2028-08-01→ Common Stock (15,649 underlying)
Other
Common Stock
2019-03-26−11,508→ 1,808 total
Other
Stock Option (Right to Buy)
2019-03-26−8,300→ 0 total
Exercise: $4.03Exp: 2021-08-09→ Common Stock (8,300 underlying)
Other
Stock Option (Right to Buy)
2019-03-26−8,297→ 0 total
Exercise: $4.03Exp: 2021-08-09→ Common Stock (8,297 underlying)

Holdings

Footnotes (6)

[F1]Reflects unvested shares of stock forfeited pursuant to Reporting Person's separation agreement in connection with his resignation from the Company.
[F2]Securities held by trusts for the benefit of the Reporting Person's family. The Reporting Person disclaims beneficial ownership of the shares held by such trusts, except to the extent of his pecuniary interest therein. The filing of this statement by the Reporting Person shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, such Reporting Person is the beneficial owners of the securities reported herein.
[F3]Reflects unexercised options forfeited pursuant to Reporting Person's separation agreement in connection with his resignation from the Company.
[F4]These options were fully vested.
[F5]An option that was to vest in three equal annual installments beginning on March 10, 2018.
[F6]An option that was to vest in three equal annual installments beginning on August 1, 2019.

Documents

1 file